Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2022

01-04-2022 | Magnetic Resonance Imaging | Case Report

Pancreatic serous cystadenocarcinoma diagnosed with liver metastasis at 7 years after the resection of the primary serous neoplastic lesion

Authors: Yutaka Takagi, Takashi Hatori, Osamu Itano, Masahiro Shinoda, Atsushi Kato, Nobuhiro Nitori, Fumihiko Kato, Ayu Kato, Atsushi Nakao, Takuya Tamura, Shuichiro Uemura, Masaru Miyazaki, Shinsuke Aida

Published in: Clinical Journal of Gastroenterology | Issue 2/2022

Login to get access

Abstract

Pancreatic serous neoplasms are rare tumors that are usually benign. However, histopathological differentiation between benign (serous cystadenoma) and malignant (serous cystadenocarcinoma) lesions is difficult. We present the case of a patient with pancreatic serous cystadenocarcinoma that was diagnosed with liver metastasis 7 years after the resection of the primary serous neoplastic lesion. A woman in her 60 s was diagnosed with pancreatic serous cystadenoma based on imaging and histopathological examination findings. The tumor was resected, and the patient was followed up every 6 months to monitor tumor progression. At 7 years after the resection of the primary lesion, liver tumors showing marked flare-like contrast enhancements were detected on arterial phase computed tomography findings and on dynamic magnetic resonance imaging findings acquired 60 s after the administration of a contrast agent. Laparoscopic segmental hepatectomy of S4 and S6 was performed to resect these tumors. Histopathological examination revealed that these tumors were metastatic and developed from the primary lesion. Therefore, a diagnosis of serous cystadenocarcinoma was confirmed. The flare-like contrast enhancement around the metastatic liver lesions on computed tomography and dynamic magnetic resonance images may be an indicator of serous cystadenocarcinoma with liver metastasis that could assist in diagnosis.
Literature
1.
go back to reference Compagno J, Oertel JE. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol. 1978;69:573–80.CrossRef Compagno J, Oertel JE. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol. 1978;69:573–80.CrossRef
2.
go back to reference Hodgkinson DJ, ReMine WH, Weiland LH. Pancreatic cystadenoma. A clinicopathologic study of 45 cases. Arch Surg. 1978;113:512–9.CrossRef Hodgkinson DJ, ReMine WH, Weiland LH. Pancreatic cystadenoma. A clinicopathologic study of 45 cases. Arch Surg. 1978;113:512–9.CrossRef
3.
go back to reference Lee SE, Kwon Y, Jang JY, et al. The morphological classification of a serous cystic tumor (SCT) of the pancreas and evaluation of the preoperative diagnostic accuracy of computed tomography. Ann Surg Oncol. 2008;15:2089–95.CrossRef Lee SE, Kwon Y, Jang JY, et al. The morphological classification of a serous cystic tumor (SCT) of the pancreas and evaluation of the preoperative diagnostic accuracy of computed tomography. Ann Surg Oncol. 2008;15:2089–95.CrossRef
4.
go back to reference Watanabe G, Matsuda M, Hashimoto M. Operative indication of serous cystic tumor. Tan Sui. 2003;24:303–10. Watanabe G, Matsuda M, Hashimoto M. Operative indication of serous cystic tumor. Tan Sui. 2003;24:303–10.
5.
go back to reference Perez-Ordonez B, Naseem A, Lieberman PH, et al. Solid serous adenoma of the pancreas. The solid variant of serous cystadenoma? Am J Surg Pathol. 1996;20:1401–5.CrossRef Perez-Ordonez B, Naseem A, Lieberman PH, et al. Solid serous adenoma of the pancreas. The solid variant of serous cystadenoma? Am J Surg Pathol. 1996;20:1401–5.CrossRef
6.
go back to reference Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon: World Health Organization; 2010. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon: World Health Organization; 2010.
7.
go back to reference The WHO Classification of Tumours Editorial Board. WHO classification of tumours of the digestive system. 5th ed. Lyon: World Health Organization; 2019. The WHO Classification of Tumours Editorial Board. WHO classification of tumours of the digestive system. 5th ed. Lyon: World Health Organization; 2019.
8.
go back to reference George DH, Murphy F, Michalski R, et al. Serous cystadenocarcinoma of the pancreas: a new entity? Am J Surg Pathol. 1989;13:61–6.CrossRef George DH, Murphy F, Michalski R, et al. Serous cystadenocarcinoma of the pancreas: a new entity? Am J Surg Pathol. 1989;13:61–6.CrossRef
9.
go back to reference Kamaya A, Maturen KE, Tye GA, et al. Hypervascular liver lesions. Semin Ultrasound CT MR. 2009;30:387–407.CrossRef Kamaya A, Maturen KE, Tye GA, et al. Hypervascular liver lesions. Semin Ultrasound CT MR. 2009;30:387–407.CrossRef
10.
go back to reference Strobel O, Zgraggen K, Schmitz-Winnenthal FH, et al. Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion. 2003;68:24–33.CrossRef Strobel O, Zgraggen K, Schmitz-Winnenthal FH, et al. Risk of malignancy in serous cystic neoplasms of the pancreas. Digestion. 2003;68:24–33.CrossRef
11.
go back to reference Kuboki Y, Shiratori K, Hatori T, et al. Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas. Mod Pathol. 2010;23:1127–35.CrossRef Kuboki Y, Shiratori K, Hatori T, et al. Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas. Mod Pathol. 2010;23:1127–35.CrossRef
12.
go back to reference Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358:1160–74.CrossRef Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358:1160–74.CrossRef
13.
go back to reference Friedman HD. Nonmucinous, glycogen-poor cystadenocarcinoma of the pancreas. Arch Pathol Lab Med. 1990;114:888–91.PubMed Friedman HD. Nonmucinous, glycogen-poor cystadenocarcinoma of the pancreas. Arch Pathol Lab Med. 1990;114:888–91.PubMed
14.
go back to reference Yoshimi N, Sugie S, Tanaka T, et al. A rare case of serous cystadenocarcinoma of the pancreas. Cancer. 1992;69:2449–53.CrossRef Yoshimi N, Sugie S, Tanaka T, et al. A rare case of serous cystadenocarcinoma of the pancreas. Cancer. 1992;69:2449–53.CrossRef
15.
go back to reference Eriguchi N, Aoyagi S, Nakayama T, et al. Serous cystadenocarcinoma of the pancreas with liver metastases. J Hepato-Bil Pancreat Surg. 1998;5:467–70.CrossRef Eriguchi N, Aoyagi S, Nakayama T, et al. Serous cystadenocarcinoma of the pancreas with liver metastases. J Hepato-Bil Pancreat Surg. 1998;5:467–70.CrossRef
16.
go back to reference Ishikawa T, Nakao A, Nomoto S, et al. Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas. Pancreas. 1998;16:40–4.CrossRef Ishikawa T, Nakao A, Nomoto S, et al. Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas. Pancreas. 1998;16:40–4.CrossRef
17.
go back to reference Galanis C, Zamani A, Cameron JL, et al. Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. J Gastrointest Surg. 2007;11:820–6.CrossRef Galanis C, Zamani A, Cameron JL, et al. Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. J Gastrointest Surg. 2007;11:820–6.CrossRef
18.
go back to reference Franko J, Cole K, Pezzi CM, et al. Serous cystadenocarcinoma of the pancreas with metachronous hepatic metastasis. Am J Clin Oncol. 2008;31:624–5.CrossRef Franko J, Cole K, Pezzi CM, et al. Serous cystadenocarcinoma of the pancreas with metachronous hepatic metastasis. Am J Clin Oncol. 2008;31:624–5.CrossRef
19.
go back to reference Bano S, Upreti L, Puri SK, et al. Imaging of pancreatic serous cystadenocarcinoma. Jpn J Radiol. 2011;29:730–4.CrossRef Bano S, Upreti L, Puri SK, et al. Imaging of pancreatic serous cystadenocarcinoma. Jpn J Radiol. 2011;29:730–4.CrossRef
20.
go back to reference Khashab MA, Shin EJ, Amateau S, et al. Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol. 2011;106:1521–6.CrossRef Khashab MA, Shin EJ, Amateau S, et al. Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol. 2011;106:1521–6.CrossRef
21.
go back to reference Kimura W, Moriya T, Hirai I, et al. Multicenter study of serous cystic neoplasm of the Japan Pancreas Society. Pancreas. 2012;41:380–7.CrossRef Kimura W, Moriya T, Hirai I, et al. Multicenter study of serous cystic neoplasm of the Japan Pancreas Society. Pancreas. 2012;41:380–7.CrossRef
22.
go back to reference Bramis K, Petrou A, Papalambros A, et al. Serous cystadenocarcinoma of the pancreas: report of a case and management reflections. World J Surg Oncol. 2012;10:51.CrossRef Bramis K, Petrou A, Papalambros A, et al. Serous cystadenocarcinoma of the pancreas: report of a case and management reflections. World J Surg Oncol. 2012;10:51.CrossRef
23.
go back to reference Rossidis G, Arroyo MR, Abbitt PL, et al. Malignant transformation of a pancreatic serous cystadenoma. Am Surg. 2012;78:260–3.CrossRef Rossidis G, Arroyo MR, Abbitt PL, et al. Malignant transformation of a pancreatic serous cystadenoma. Am Surg. 2012;78:260–3.CrossRef
24.
go back to reference Bassam AW, Keough V, Huang WY, et al. Histological percutaneous diagnosis of stage IV microcystic serous cystadenocarcinoma of the pancreas. BMJ Case Rep. 2013;2013:bcr2012007924.CrossRef Bassam AW, Keough V, Huang WY, et al. Histological percutaneous diagnosis of stage IV microcystic serous cystadenocarcinoma of the pancreas. BMJ Case Rep. 2013;2013:bcr2012007924.CrossRef
25.
go back to reference Kainuma O, Yamamoto H, Cho A, et al. Solid variant type of serous cystadenocarcinoma of the pancreas: a case report and review of the literature. Pancreatology. 2015;15:197–9.CrossRef Kainuma O, Yamamoto H, Cho A, et al. Solid variant type of serous cystadenocarcinoma of the pancreas: a case report and review of the literature. Pancreatology. 2015;15:197–9.CrossRef
26.
go back to reference Machado MC, Fonseca GM, de Meirelles LR, et al. Synchronous resection of pancreatic serous cystadenocarcinoma and liver metastasis: first reported case and review of literature. Pancreatology. 2015;15:708–12.CrossRef Machado MC, Fonseca GM, de Meirelles LR, et al. Synchronous resection of pancreatic serous cystadenocarcinoma and liver metastasis: first reported case and review of literature. Pancreatology. 2015;15:708–12.CrossRef
27.
go back to reference Van Dyke TJ, Johlin FC, Bellizzi AM, et al. Serous cystadenocarcinoma of the pancreas: clinical features and management of a rare tumor. Dig Surg. 2016;33:240–8.CrossRef Van Dyke TJ, Johlin FC, Bellizzi AM, et al. Serous cystadenocarcinoma of the pancreas: clinical features and management of a rare tumor. Dig Surg. 2016;33:240–8.CrossRef
28.
go back to reference Huh J, Byun JH, Hong SM, et al. Malignant pancreatic serous cystic neoplasms: systematic review with a new case. BMC Gastroenterol. 2016;16:97.CrossRef Huh J, Byun JH, Hong SM, et al. Malignant pancreatic serous cystic neoplasms: systematic review with a new case. BMC Gastroenterol. 2016;16:97.CrossRef
29.
go back to reference Sasaki H, Murakami Y, Uemura K, et al. Education and imaging. Hepatobiliary and pancreatic: long-term survival of serous cystadenocarcinoma of the pancreas with synchronous liver metastases after aggressive surgical resection. J Gastroenterol Hepatol. 2016;31:287.CrossRef Sasaki H, Murakami Y, Uemura K, et al. Education and imaging. Hepatobiliary and pancreatic: long-term survival of serous cystadenocarcinoma of the pancreas with synchronous liver metastases after aggressive surgical resection. J Gastroenterol Hepatol. 2016;31:287.CrossRef
30.
go back to reference Kawai M, Fukuda A, Yogo A, et al. A case of a malignant serous neoplasm of the pancreas with synchronous vascular invasion and metachronous metastases. Clin J Gastroenterol. 2020;13:1347–54.CrossRef Kawai M, Fukuda A, Yogo A, et al. A case of a malignant serous neoplasm of the pancreas with synchronous vascular invasion and metachronous metastases. Clin J Gastroenterol. 2020;13:1347–54.CrossRef
31.
go back to reference Massaras D, Pantiora EV, Koutalas J, et al. Serous microcystic cystadenocarcinoma of the pancreas with synchronous liver metastases: clinical characteristics and management. Cureus. 2020;12:e7707.PubMedPubMedCentral Massaras D, Pantiora EV, Koutalas J, et al. Serous microcystic cystadenocarcinoma of the pancreas with synchronous liver metastases: clinical characteristics and management. Cureus. 2020;12:e7707.PubMedPubMedCentral
Metadata
Title
Pancreatic serous cystadenocarcinoma diagnosed with liver metastasis at 7 years after the resection of the primary serous neoplastic lesion
Authors
Yutaka Takagi
Takashi Hatori
Osamu Itano
Masahiro Shinoda
Atsushi Kato
Nobuhiro Nitori
Fumihiko Kato
Ayu Kato
Atsushi Nakao
Takuya Tamura
Shuichiro Uemura
Masaru Miyazaki
Shinsuke Aida
Publication date
01-04-2022
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 2/2022
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01570-9

Other articles of this Issue 2/2022

Clinical Journal of Gastroenterology 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.